Quest Diagnostics Inc
NYSE:DGX
Quest Diagnostics Inc
NYSE:DGX
Price:
137.55 USD
-0.46%
Market Closed
Updated:
May 2, 2024
Quest Diagnostics Inc
Cash from Operating Activities
|
Quest Diagnostics Inc
Cash from Operating Activities Peer Comparison
Comparables:
DVA
CHE
CVS
CI
LH
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Operating Activities
$1.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Chemed Corp
NYSE:CHE
|
Cash from Operating Activities
$354.4m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
10%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Operating Activities
$13.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Operating Activities
$11.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
26%
|
CAGR 10-Years
32%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Operating Activities
$1.2B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
See Also
What is Quest Diagnostics Inc's Cash from Operating Activities?
Cash from Operating Activities
1.3B
USD
1.3B
USD
Based on the financial report for Mar 31, 2024, Quest Diagnostics Inc's Cash from Operating Activities amounts to 1.3B USD.
What is Quest Diagnostics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
6%
6%
Over the last year, the Cash from Operating Activities growth was 0%. The average annual Cash from Operating Activities growth rates for Quest Diagnostics Inc have been -19% over the past three years , 1% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
